Clonic hemifacial spasm
Methodology & AI Transparency ⓘ
Clonic hemifacial spasm Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code G51.39 in Brain & Neurology, Clonic hemifacial spasm requires neurorehabilitation tracking [Clonic hemifacial spasm G51.39] so specialists can calibrate treatment intensity against Serum Vitamin B12 in Clonic hemifacial spasm (G51.39: & Methylmalonic Acid) benchmarks.
- 2 Real-world patient consensus: Diagnostic registry G51.39: Clonic hemifacial spasm is managed within Brain & Neurology.
- 3 Typical cash cost range: Workup highlights for Clonic hemifacial spasm (G51.39): neurorehabilitation tracking [Clonic hemifacial spasm G51.39].
- 4 Top reported side effects / signs: Longitudinal Clonic hemifacial spasm monitoring tracks Serum Vitamin B12 in Clonic hemifacial spasm (G51.39: & Methylmalonic Acid) toward B12 > 500 pg/mL; MMA < 240 nmol/L (G51.39).
Ask our AI Specialists anything about Clonic hemifacial spasm
What Is Clonic hemifacial spasm?
Cataloged under federal diagnostic code G51.39 in Brain & Neurology, Clonic hemifacial spasm requires neurorehabilitation tracking [Clonic hemifacial spasm G51.39] so specialists can calibrate treatment intensity against Serum Vitamin B12 in Clonic hemifacial spasm (G51.39: & Methylmalonic Acid) benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Clonic hemifacial spasm (G51.39) center on blood-brain barrier neuroinflammation [Clonic hemifacial spasm G51.39]. targeted brain & neurology interventions aim to normalize Serum Vitamin B12 in Clonic hemifacial spasm (G51.39: & Methylmalonic Acid).
Common Symptoms & Clinical Signs
- • Presentation of Clonic hemifacial spasm (G51.39): episodic vertigo, imbalance, in Clonic hemifacial spasm (G51.39: coordination drift, or)
- • Secondary Clonic hemifacial spasm clinical sign: numbness, paresthesia, or in Clonic hemifacial spasm (G51.39: visual field/speech changes)
- • Symptom flares in Clonic hemifacial spasm correlating with Serum Vitamin B12 in Clonic hemifacial spasm (G51.39: & Methylmalonic Acid) deviation outside B12 > 500 pg/mL; MMA < 240 nmol/L (G51.39)
- • Functional brain & neurology impact requiring neurorehabilitation tracking [Clonic hemifacial spasm G51.39] evaluation (G51.39)
Clonic hemifacial spasm Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | G51.39 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Neurology, Stroke & Movement Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Clonic hemifacial spasm (G51.39: & Methylmalonic Acid) | B12 > 500 pg/mL; MMA < 240 nmol/L (G51.39) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Carotid Duplex / in Clonic hemifacial spasm (G51.39: Cerebral Perfusion) | No hemodynamically significant stenosis (G51.39) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Blood in Clonic hemifacial spasm (G51.39: Pressure Neuro-Targets) | BP < 120/75 mmHg; HbA1c < 5.7% (G51.39) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Clonic hemifacial spasm
Treatment selection for Clonic hemifacial spasm depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Clonic hemifacial spasm)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Efficacy, safety, and tolerability of adjunctive perampanel in patients from Adjunctive perampanel (up to 12 mg/day) may be a suitable treatment for Chinese patients with FS, with/without FBTCS, or GTCS, with similar real-world benefits and safety/tolerability compared to non-Chinese patients. CNS neuroscience & therapeutics • 2021-03-15 • Phase III Randomized Trial | N = 79 | 88/100 | PMID 33340263 ↗ |
| Can This Approach Help? Inside the Latest Research on Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter Findings reported here add new insights into the complex mechanisms of pseudo-atrophy and its relation to the compartmentalized inflammation occurring in the GM of MS patients. Annals of clinical and translational neurology • 2021-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33534940 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of adjunctive perampanel in patients with focal seizures or 128 patients (placebo, n = 39; perampanel, n = 89) were included in the gold-standard blind Safety Analysis Set and 126 (FS, n = 113 [placebo, n = 32; perampanel, n = 81]; FBTCS, n = 35 [placebo, n = 14; perampanel, n = 21];... Epilepsia open • 2021-03-15 • Phase III Randomized Trial | N = 39 | 88/100 | PMID 33681652 ↗ |
Clonic hemifacial spasm Patient Community & “People Like Me” Threads
Filter Clonic hemifacial spasm community threads and patient logs by age, biological sex, dosage, and treatment duration.